Self-optimization is the next evolutionary step for bioprocessing purification systems and, although that step is near, it ...

Emerging technologies like laboratory automation and generative AI are promising to revolutionize bioindustry workflows.

Vivodyne says that eight of the world’s largest pharma companies have paid for early access to the human biological datacenter platform.

MADM organoid. Fluorescent image of a mouse cortical organoid. Cells with MADM labeling (green, red, yellow) are clearly visible; the blue is DAPI nuclear staining. The MADM-labeled cells are mostly ...

Bristol Myers Squibb has selected Houston as the site for a new $2.3 billion multi-modal manufacturing campus designed to support drug product and finished goods manufacturing from late development ...

A scalable platform to discover molecular glue degraders has been developed, identifying the first metabolically activated ...

Zebrafish were bred to lack a working copy of a gene that could be studied to better understand how genetic faults could lead ...

COVID-19 can reactivate dormant viruses, including Epstein-Barr and cytomegalovirus, according to a large NIH-funded study.

In GEN’s flagship virtual event, The State of Biotech, we hear from a distinguished group of business executives, award-winning scientists, and journalists.

The puppies represent a key first step towards addressing canine allergenicity and mark potentially a significant advance in ...

The team’s approach, which combines synthetic biology expertise, artificial intelligence, and statistical mapping techniques, enables rapid, precise reprogramming of bacteria as biotechnology tools, ...

With the organoid working to simulate a heart with valves, the researchers had a model they could use to study four types of valve disorders.